CMCO vs REGN · rev $963.0M vs P/E 14, rev $14.34B
Columbus McKinnon Corporation (CMCO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Columbus McKinnon Corporation (CMCO) is a farm & heavy construction machinery company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CMCO revenue for 2025-03-31 was $963.0M. Net income was -$5.1M. Revenue was down 5.0% from 2024-03-31 to 2025-03-31. CMCO currently screens at market cap $465.9M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CMCO currently screens at market cap $465.9M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CMCO and REGN stock pages for the full models.
Not investment advice.